1. Home
  2. TECH vs FCNCP Comparison

TECH vs FCNCP Comparison

Compare TECH & FCNCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • FCNCP
  • Stock Information
  • Founded
  • TECH 1976
  • FCNCP N/A
  • Country
  • TECH United States
  • FCNCP United States
  • Employees
  • TECH N/A
  • FCNCP 17475
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • FCNCP Major Banks
  • Sector
  • TECH Health Care
  • FCNCP Finance
  • Exchange
  • TECH Nasdaq
  • FCNCP Nasdaq
  • Market Cap
  • TECH 8.3B
  • FCNCP N/A
  • IPO Year
  • TECH 1989
  • FCNCP N/A
  • Fundamental
  • Price
  • TECH $51.26
  • FCNCP $21.68
  • Analyst Decision
  • TECH Buy
  • FCNCP
  • Analyst Count
  • TECH 12
  • FCNCP 0
  • Target Price
  • TECH $70.91
  • FCNCP N/A
  • AVG Volume (30 Days)
  • TECH 2.0M
  • FCNCP N/A
  • Earning Date
  • TECH 10-29-2025
  • FCNCP N/A
  • Dividend Yield
  • TECH 0.62%
  • FCNCP N/A
  • EPS Growth
  • TECH N/A
  • FCNCP N/A
  • EPS
  • TECH 0.46
  • FCNCP N/A
  • Revenue
  • TECH $1,219,635,000.00
  • FCNCP N/A
  • Revenue This Year
  • TECH $4.13
  • FCNCP N/A
  • Revenue Next Year
  • TECH $7.56
  • FCNCP N/A
  • P/E Ratio
  • TECH $111.46
  • FCNCP N/A
  • Revenue Growth
  • TECH 5.23
  • FCNCP N/A
  • 52 Week Low
  • TECH $46.01
  • FCNCP N/A
  • 52 Week High
  • TECH $80.95
  • FCNCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • TECH 42.09
  • FCNCP 46.14
  • Support Level
  • TECH $50.87
  • FCNCP $21.56
  • Resistance Level
  • TECH $54.62
  • FCNCP $21.90
  • Average True Range (ATR)
  • TECH 1.85
  • FCNCP 0.33
  • MACD
  • TECH -0.37
  • FCNCP -0.08
  • Stochastic Oscillator
  • TECH 7.31
  • FCNCP 39.42

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About FCNCP First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: